The clinical testing services startup has secured funding in a round co-led by Qualcomm and Novartis vehicle dRx Capital.
US-based clinical research services provider Science 37 closed a $6.5m series A round on Tuesday co-led by dRx Capital, the joint venture between semiconductor technology producer Qualcomm and pharmaceutical firm Novartis.
The round was co-led with venture capital firm Lux Capital. Science 37 has not disclosed details of any seed funding.
Science 37 uses mobile engagement and locally-delivered medical services to make clinical testing more efficient. It will use the funding to develop and roll out its operating model.
Lucian…
